1-3 of 3
Chava Perry, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-Life Experience of Nivolumab in Heavily Pretreated Relapsed and Refractory Classical Hodgkin Lymphoma

Ohad Benjamini, MD, David Lavie, MD, Eldad J Dann, MD, Chava Perry, MDPhD, Ory Rouvio, MD, Olga Shvetz, MD, Anatoly Nemets, MD, Ruth Perets, MD PhD, Revital Saban, MD, Avichai Shimoni, MD, Dina Ben-Yehuda, MD, Arnon Nagler, Abraham Avigdor, MD
Journal: Blood
Blood (2016) 128 (22): 3008.
https://doi.org/10.1182/blood.V128.22.3008.3008
Published: 2016
Journal Articles

SLP76 Is Ectopically Expressed in Chronic Lymphocytic Leukemia Cells and Involves in B-Cell Receptor Signaling

Yair Herishanu, MD, Nili Dorozella, Mika Shapiro, PhD, Chava Perry, MDPhD, Ben-Zion Katz, PhD
Journal: Blood
Blood (2015) 126 (23): 1719.
https://doi.org/10.1182/blood.V126.23.1719.1719
Published: 2015
Journal Articles

Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation

Dana Rosenberg, MD, Erel Joffe, MDMSc, Uri Rozovski, MD, Chava Perry, MDPhD, Ilya Kirgner, MD, Svetlana Trestman, MD, Odelia Gur, Freddy Aviv, MD, Nadav Sarid, MD, Albert Kolomansky, MD, Lily Gepstein, Yair Herishanu, MD, Elizabeth Naparstek, MD
Journal: Blood
Blood (2015) 126 (23): 3188.
https://doi.org/10.1182/blood.V126.23.3188.3188
Published: 2015